Symbols

TVTX

Travere Therapeutics·NASDAQ

--(--)

TVTX Filings

2026-03-27 ·

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

2026-03-18 · Ownership

Form 4 - Statement of changes in beneficial ownership of securities

2026-03-16 · Ownership

Form 144 - Report of proposed sale of securities

2026-02-24 · Ownership

Form 4 - Statement of changes in beneficial ownership of securities

2026-02-20 · Ownership

Form 144 - Report of proposed sale of securities

2026-02-19 · Earnings Call

Travere Therapeutics, Inc. (TVTX) Q4 2025 Earnings Call Transcript

2026-02-19 · Financials

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

2026-02-19 · Ownership

Form 4 - Statement of changes in beneficial ownership of securities

2026-02-19 · Key Events

Form 8-K - Current report

2026-02-17 ·

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]